Evidence map›Paper›PMID 28576855›Full record

Trial reportPhysiological reports2017

Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin-angiotensin-aldosterone and dopaminergic systems in acute phase of ARB therapy.

Yukako Isobe-Sasaki, Michio Fukuda, Yoshiaki Ogiyama, Ryo Sato, Toshiyuki Miura, Daisuke Fuwa, Masashi Mizuno, Tetsuhei Matsuoka, Hiroko Shibata, Hiroyuki Ito and 8 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Physiological reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Yukako Isobe-SasakiDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Michio FukudaDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan m-fukuda@med.nagoya-cu.ac.jp.ORCID http://orcid.org/0000-0002-7455-5776
Yoshiaki OgiyamaDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Ryo SatoDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Toshiyuki MiuraDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Daisuke FuwaDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Masashi MizunoDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Tetsuhei MatsuokaDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Hiroko ShibataDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Hiroyuki ItoDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Minamo OnoDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Sumiko Abe-DohmaeDepartment of Biochemistry, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Ken KiyonoDepartment of Mechanical Science and Bioengineering, Osaka University, Osaka, Japan.
Yoshiharu YamamotoDepartment of Physical and Health Education, University of Tokyo Graduate School of Education, Tokyo, Japan.
Hiroyuki KoboriInternational University of Health and Welfare, Tokyo, Japan.
Makoto MichikawaDepartment of Biochemistry, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Junichiro HayanoDepartment of Medical Education, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Nobuyuki OhteDepartment of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Nagoya City University · JPInternational University of Health and Welfare · JPJapan Graduate School of Education University · JPOsaka Health Science University · JP

Funding

Intrarenal Augmentation of Angiotensinogen by Ang IIR01DK072408 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI NAVAR, LUIS GABRIEL · 2006 to 2010
$1.2M
NIDDK NIH HHS R01 DK072408
6 · The paper itself

Abstract

We have revealed that even in humans, activated intrarenal renin-angiotensin-aldosterone system (RAAS) enhances tubular sodium reabsorption to facilitate salt sensitivity and nondipper rhythm of blood pressure (BP), and that angiotensin receptor blocker (ARB) could increase daytime urinary sodium excretion rate (U

Indexed as

Blood PressureHeart RateRenin-Angiotensin SystemAdultAgedAngiotensin Receptor AntagonistsBenzimidazolesCircadian RhythmDopamineFemaleHumansMaleMiddle AgedOxadiazolesRenal Insufficiency, ChronicSodiumAngiotensin Receptor AntagonistsazilsartanBenzimidazolesDopamineOxadiazolesSodiumAngiotensinogenchronic kidney diseasedopamineheart rate variability

Identifiers

PMID28576855
PMCPMC5471446
OpenAlexW2621157756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.